Clinical trial
An Open-label, Multicenter, Rollover Study in Patients Who Participated in an Avapritinib Clinical Study
NCT06748001 is registered in ClinicalTrials.gov with Blueprint Medicines Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multicenter, Rollover Study in Patients Who Participated in an Avapritinib Clinical Study
- Lead sponsor
- Blueprint Medicines Corporation
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 28, 2024
- Completion date
- December 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.